Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Cold Cure Labs is stocked at 55 licensed dispensaries across Colorado, with the deepest coverage in Denver, Colorado Springs, Aurora, Boulder, and Broomfield. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Cold Cure Labs concentrated nearly half of September 2026 sales in Vapor Pens at 48.47% share, yet that anchor category declined both year over year by 3.93% and month over month by 32.75%, while Concentrates rose 22.02% YoY but dropped 40.26% MoM, and Pre-Roll fell 26.61% YoY and 43.61% MoM. With Vapor Pens ranked 57th in Colorado and the brand’s overall sales down 3.73% YoY alongside a 0.82% YoY uptick in average price, the pattern implies a reliance on a leading category that is softening sequentially, with growth pockets (Concentrates YoY) not yet offsetting sharp monthly pullbacks.
The category reweighting signals a positioning challenge: a premium-leaning mix (Vapor Pens avg price $40.19 vs. Pre-Roll $11.63) that is experiencing steeper MoM volume pressure in lower-priced Pre-Rolls at -43.61% MoM while the higher-priced Vapor Pens also contracted -32.75% MoM, suggesting limited short-term elasticity across tiers. Given Concentrates’ 22.02% YoY rise but 40.26% MoM dip and Vapor Pens’ 48.47% share paired with a Colorado category rank of 57, the brand’s near-term positioning hinges on stabilizing its largest premium category while leaning into the relatively better YoY momentum in Concentrates to mitigate sequential volatility.
Competitive Landscape
Cold Cure Labs ranks #57 in CO Vapor Pens in September 2026, improving 7 positions from #64 year over year, and up 11 spots versus June 2026’s #68; however, it sits 5 places below its peak of #52 reached in August 2026, indicating a recent pullback after a summer high. Against category leaders, Spherex held #1 with a 1.9% YoY sales increase while Cold Cure Labs stayed outside the top 50, and PAX advanced from #3 to #2 on 34.7% YoY sales growth as Cold Cure Labs gained only 7 ranks over the year; with Jetty Extracts jumping from #15 to #4 alongside 150.9% YoY growth, the widening gap suggests Cold Cure Labs’ incremental rank lift is being outpaced by faster-moving rivals. The pattern implies Cold Cure Labs is improving but risks being boxed into the mid-tier unless it converts short-term rank momentum into sustained share capture against brands climbing multiple tiers.

Notable Products
Citrine Dream Rosin Infused Pre-Roll (1g) posted the steepest shift in September 2026 with a -61.6% month-over-month drop while falling to rank 3, contrasted by Swamp Fruit Rosin Infused Pre-Roll (1g) rising +54.0% MoM to rank 1. Pre-Rolls account for four of the top ten SKUs, with rank positions at 1, 2, 3, and 8 indicating tighter concentration even as one title collapsed by -61.6% and another expanded by +54.0%. This pattern implies Cold Cure Labs is leaning into Pre-Rolls as a volume anchor while absorbing volatility at the SKU level to maintain category-level share.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






